Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DX25FVHDJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $147,325
Award facts
- Contract value 100% obligated
- $147,324.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a $147,324.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside competitive award represents a child delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as the company's primary mechanism for supplying pharmaceutical products and medical supplies to military healthcare systems globally. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
RINVOQ ER (upadacitinib) is an oral Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, making this delivery order part of AmerisourceBergen's broader portfolio of specialty medications supporting Defense Health Agency and other federal healthcare system requirements. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen routinely fulfills delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through its comprehensive DLA prime contract vehicle, enabling efficient and flexible pharmaceutical support to military personnel and beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DX25FVHDJ?
SPE2DX25FVHDJ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DX25FVHDJ worth?
The government has obligated $147,325 on SPE2DX25FVHDJ.
Is contract SPE2DX25FVHDJ an order under another contract?
Yes. SPE2DX25FVHDJ is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVHDJ competed?
The extent of competition for SPE2DX25FVHDJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award